Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 1,727 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AIMS Clear all

Conditions: Stenotrophomonas Maltophilia Infection
Interventions: Antibiotic; Drug
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Intimate Partner Violence
Interventions: Manage Emotions to Reduce Aggression- Couples, Manage Emotions to Reduce Aggression; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Spinal Cord Injuries
Interventions: Biofeedback; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Histoplasmosis
Interventions: LAmB B, Posaconazole, World Health Organization (WHO)-recommended SOC, WHO-recommended SOC Itraconazole; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 664 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Breast Cancer, Endometrial Cancer
Interventions: HLA vaginal gel (HyaloGYN®),, questionnaires; Other · Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Disease
Interventions: LINKS; Behavioral
Lead sponsor: Abby Lohr; Other
Eligibility: 21 Years and older
Enrollment: 189 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Nogales, Arizona • Tucson, Arizona • Yuma, Arizona

Conditions: Smoking, Smoking Behaviors, Nicotine Dependence
Interventions: E-cigarette with 2.4% Nicotine with Menthol and Tobacco Flavors, E-cigarette with 2.4% Nicotine with Tobacco Flavor Only, E-cigarette with 5% Nicotine with Menthol and Tobacco Flavors, E-cigarette with 5% Nicotine with Tobacco Flavor Only, Tobacco Pouches with 3mg Nicotine with Menthol and Tobacco Flavors, Tobacco Pouches with 3mg Nicotine with Tobacco Flavor Only, Tobacco Pouches with 6mg Nicotine with Menthol and Tobacco Flavors, Tobacco Pouches with 6mg Nicotine with Tobacco Flavor Only; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 21 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Childhood Obesity
Interventions: 4-Health Educational curriculum, Healthy Living Information; Behavioral
Lead sponsor: Montana State University; Other
Eligibility: Not listed
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Cervical Insufficiency, Preterm Birth, Cervical Length Measurement
Interventions: Cervical Length Measurement at the Beginning of the Anatomy Survey, Cervical Length Measurement at the End of the Anatomy Survey; Procedure
Lead sponsor: Henry Ford Health System; Other
Eligibility: Female only
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Firearm Injury, Safety Issues
Interventions: Adopting Comprehensive Training for FireArm Safety in Trauma Centers; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 1,776 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Baltimore, Maryland • York, Pennsylvania

Conditions: HIV
Interventions: Lenacapavir long-acting, Standard of Care (SOC); Drug · Other
Lead sponsor: Kelley-Ross & Associates, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Nurse, Burnout, Healthcare Workers
Interventions: RESTORE; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 470 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: HIV-1 Infection
Interventions: Isotretinoin; Drug
Lead sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections; Network
Eligibility: 18 Years to 80 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 10 more

Conditions: HIV/AIDS, Methamphetamine Abuse, Depression
Interventions: MoodGym; Behavioral
Lead sponsor: Friends Research Institute, Inc.; Other
Eligibility: Male only
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Postoperative Nausea and Vomiting
Interventions: Automated recommendation at the start of the case, Automated notification at the start of surgery, Preoperative recommendations: by email, Automated notification at the end of surgery, Anesthesia Information Management System (AIMS), Perioperative Data Warehouse (PDW), General anesthesia, Elective surgery, Propofol, Sevoflurane, Isoflurane, Desflurane, Scopolamine, Droperidol, Haloperidol, Dexamethasone, Promethazine, Meclizine, Aprepitant, Metoclopramide, Fentanyl, Sufentanil, Alfentanil, Remifentanil, Morphine, Meperidine, Hydromorphone, Methadone, Oxycodone, Oxymorphone, Hydrocodone, Ketamine, Ondansetron, Granisetron, Dolasetron mesylate, Palonosetron, Tropisetron, Ramosetron; Procedure · Device · Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 27,034 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Suicide and Depression, Adolescent Behavior
Interventions: iCHART, Treatment As Usual; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Years to 18 Years
Enrollment: 765 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 13
States / cities: Gibbsboro, New Jersey • Johnstown, Pennsylvania • Philadelphia, Pennsylvania + 4 more

Conditions: To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion
Interventions: Intravenous administration of indocyanine green (SPY Agent Green) 2 mL of SPY Agent Green (5.0 mg dose), Intravenous administration of indocyanine green (SPY Agent Green) 3 mL of SPY Agent Green (7.5 mg dose), Intravenous administration of indocyanine green (SPY Agent Green) 4 mL of SPY Agent Green (10 mg dose), Intravenous administration of indocyanine green (SPY Agent Green)5 mL of SPY Agent Green (12.5 mg dose); Combination Product
Lead sponsor: Henry Ford Health System; Other
Eligibility: 14 Years to 89 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pediatric Cancer, Adolescent and Young Adult Cancer
Interventions: ReSPECT; Behavioral
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 15 Years to 25 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Weight Loss
Interventions: Weekly Incentive; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Behavioral Health
Interventions: Bodhi AIM (intervention group), HIB (control group); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 13 Years to 18 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Asthma
Interventions: Group Classes; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 4 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Rett Syndrome
Interventions: Not listed
Lead sponsor: University of South Florida; Other
Eligibility: 3 Years to 18 Years · Female only
Enrollment: 146 participants
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Cerebral Palsy
Interventions: tSCS, 5-Azacitidine, Mannitol, Functional Activity Training; Other · Drug
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 4 Years to 17 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)
Interventions: Milk thistle (MT), Placebo, Lifestyle Modification, Fibroscan; Drug · Behavioral · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 9 Years to 22 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia

Adapting the Manage Emotions to Reduce Aggression Therapy to Reduce Intimate Partner Violence and Promote Psychosocial Recovery in Veteran Couples (MERA-C)

Biofeedback for Wheelchair Users

Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)

Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health

Linking Individual Needs to Community and Clinical Services

Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction

Family Influences to Prevent Childhood Obesity

Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey

Adult Trauma Centers RE-AIM at Gun Safety

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Adaptation and Evaluation of RESTORE

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Clinical Trial for Integrated Care to Help At Risk Teens (iCHART) Intervention

ICG Fluorescence in Knee Arthroscopy Study

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

Helping Employees Lose Pounds

Feasibility Testing a Meditation App for Youth in the Legal System

Family Learning on Asthma Topics

Development of a Behavioral Outcome Measure for Rett Syndrome (RettBe)

tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy

Milk Thistle Clinical Trial in Pediatric NAFLD